🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

David Houghton 🧠 Alberto J Espay Michele Tagliati Ochsner Health is there any arrangements for virtual sessions?

Another #interactive #cme Movement Disorders Review 2022, endorsed by the MDS, just completed in #neworleans. We had #lectures by torticollis, Alberto J Espay and Michele Tagliati, plus David Houghton as our local co-Chair. #tremors, #dystonia, #parkinsonsdisease

David Houghton 🧠 MDS Ochsner Health Thank you, David, for chairing this great event. We all enjoyed your talk on digital health!

سال ۲۰۲۲ سال شکوه همبستگی ایرانیان با هر باور و زبان و گرایش بود. با سازماندهی و همبستگی، سال ۲۰۲۳ سال پیروزی ملت ایران خواهد بود؛ سال تحقق آزادی و عدالت در ایران. #مهسا_امینی #IranRevolution

The year 2022 was a glorious year of solidarity for Iranians of every belief, language and orientation. With organization and solidarity, 2023 will be the year of victory for the Iranian nation. The year of freedom and justice in Iran. #MahsaAmini‌ #IranRevolution

We asked ChatGPT to create an abstract about a specific study with background, methods, results, & conclusions plus measurements. Then we compared it to one by researchers published in a neurology journal. Can you tell the difference? Comment with your pick!

The Movement Disorders 2023 #cme #course, endorsed by the International Movement Disorder Society, was back in #sanfrancisco today. @OstremJill co-chaired a rich #curriculum including #lectures by Alberto J Espay, Michele Tagliati and torticollis Next #meeting in #sandiego on June 16

Mov Disord. 2013 Jul 18 Diffusion, spread, and migration of botulinum toxin Ramirez-Castaneda, Jankovic, Comella, Dashtipour, Fernandez, Mar

Pharmacotherapy. 2013 Mar;33(3):304-18 Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Chen JJ, Dashtipour K.

Mov Disord. 2013 Jun 15;28(7):874-83 Dystonia rating scales: Critique and recommendations Albanese A, Sorbo FD, Comella C, et al.

Eur J Neurol. 2013 Mar;20(3) Xeomin(®) use in patients with systemic immune reactions to other botulinum toxins type A Ricciardi, et al.

BMC Neurol. 2013 Jul Cervical dystonia: effectiveness of a standardized physical therapy program van den Dool J, et al.

Cervical Dystonia Chapter 10 Handbook of Dystonia, 2nd Edition Dashtipour & Lew Edited by Mark A . Stacy CRC Press; Published May 2012

Dystonia rating scales: Critique and recommendations. Albanese et. al. Mov Disord. 2013 Jun 15;28(7):874-83. ncbi.nlm.nih.gov/pubmed/23893443

Diffusion, spread, and migration of botulinum toxin Mov Disord. 2013 Jul 18 ncbi.nlm.nih.gov/pubmed/23868503

Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Chen & Dashtipour Pharmacotherapy. 2013 ncbi.nlm.nih.gov/pubmed/23400888

The Movement Disorder Society (MDS) becomes the International Parkinson and Movement Disorder Society. bit.ly/15tohP2

How long does it take to diagnose cervical dystonia? Tiderington E, et al. J Neurol Sci. 2013 Aug 30 ncbi.nlm.nih.gov/pubmed/24034410

Systematic Literature Review of Abobot... [Am J Phys Med Rehabil. 2014] - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/25299523

Do genetic factors protect against Parkinson's disease? What I can learn from my healthy grandma sciencedirect.com/science/articl…